Published in J Biol Chem on December 01, 1995
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A (1997) 1.38
An insight into the sialome of the blood-sucking bug Triatoma infestans, a vector of Chagas' disease. Insect Biochem Mol Biol (2007) 1.26
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J (2000) 1.08
An insight into the transcriptome of the digestive tract of the bloodsucking bug, Rhodnius prolixus. PLoS Negl Trop Dis (2014) 1.03
The sialotranscriptome of the blood-sucking bug Triatoma brasiliensis (Hemiptera, Triatominae). Insect Biochem Mol Biol (2007) 1.00
Tsetse thrombin inhibitor: bloodmeal-induced expression of an anticoagulant in salivary glands and gut tissue of Glossina morsitans morsitans. Proc Natl Acad Sci U S A (1998) 1.00
Structure and mechanism in salivary proteins from blood-feeding arthropods. Toxicon (2009) 0.95
An insight into the sialome of Simulium guianense (DIPTERA:SIMulIIDAE), the main vector of River Blindness Disease in Brazil. BMC Genomics (2011) 0.90
An insight into the sialotranscriptome of the seed-feeding bug, Oncopeltus fasciatus. Insect Biochem Mol Biol (2007) 0.88
Brasiliensin: A novel intestinal thrombin inhibitor from Triatoma brasiliensis (Hemiptera: Reduviidae) with an important role in blood intake. Int J Parasitol (2007) 0.87
An insight into the sialotranscriptome of Triatoma matogrossensis, a kissing bug associated with fogo selvagem in South America. Am J Trop Med Hyg (2012) 0.85
A repertoire of the dominant transcripts from the salivary glands of the blood-sucking bug, Triatoma dimidiata, a vector of Chagas disease. Infect Genet Evol (2009) 0.85
Salivary apyrases of Triatoma infestans are assembled into homo-oligomers. Biochem J (2006) 0.85
Structure and ligand-binding properties of the biogenic amine-binding protein from the saliva of a blood-feeding insect vector of Trypanosoma cruzi. Acta Crystallogr D Biol Crystallogr (2012) 0.81
An insight into the sialotranscriptome of Triatoma rubida (Hemiptera: Heteroptera). J Med Entomol (2012) 0.81
The "Vampirome": Transcriptome and proteome analysis of the principal and accessory submaxillary glands of the vampire bat Desmodus rotundus, a vector of human rabies. J Proteomics (2013) 0.81
Disintegrins from hematophagous sources. Toxins (Basel) (2012) 0.79
Thrombin inhibitors from different animals. J Biomed Biotechnol (2010) 0.79
Venoms of Heteropteran Insects: A Treasure Trove of Diverse Pharmacological Toolkits. Toxins (Basel) (2016) 0.78
An updated insight into the Sialotranscriptome of Triatoma infestans: developmental stage and geographic variations. PLoS Negl Trop Dis (2014) 0.77
Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids. Front Immunol (2016) 0.76
Optimization of the production of triabin, a novel thrombin inhibitor, in High Five™ insect cells infected with a recombinant baculovirus. Cytotechnology (1999) 0.76
A Deep Insight into the Sialome of Rhodnius neglectus, a Vector of Chagas Disease. PLoS Negl Trop Dis (2016) 0.76
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
U2 RNA shares a structural domain with U1, U4, and U5 RNAs. EMBO J (1982) 4.68
Nuclear localization and DNA binding of the transforming gene product of avian myelocytomatosis virus. Nature (1982) 3.64
Complementary DNA for human T-cell cyclophilin. EMBO J (1987) 2.82
Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem (2000) 2.60
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J (1987) 2.23
Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem (1989) 1.93
A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem (1991) 1.52
Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47
Post-translational modifications of steroid receptors. Biomed Pharmacother (2006) 1.44
The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem (1990) 1.43
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A (1997) 1.38
Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2. EMBO J (1989) 1.38
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest (1997) 1.37
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem (1986) 1.33
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol (1987) 1.32
High evolutionary conservation of the secondary structure and of certain nucleotide sequences of U5 RNA. Nucleic Acids Res (1983) 1.17
The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. Eur J Biochem (1996) 1.16
Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion. J Cell Biol (1989) 1.14
Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology (1991) 1.13
Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors. Biophys J (1995) 1.12
Association of gag-myc proteins from avian myelocytomatosis virus wild-type and mutants with chromatin. EMBO J (1982) 1.11
Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer (1986) 1.10
Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur J Biochem (1998) 1.08
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region. J Biol Chem (1985) 1.07
Methanol induction optimization for scFv antibody fragment production in Pichia pastoris. Biotechnol Bioeng (2004) 1.06
Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett (1993) 1.06
New androgen response elements in the murine pem promoter mediate selective transactivation. Mol Endocrinol (2001) 1.04
An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis. J Biol Chem (1994) 1.03
Decreased DNA-binding ability of purified transformation-specific proteins from deletion mutants of the acute avian leukemia virus MC29. Proc Natl Acad Sci U S A (1983) 1.03
Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. J Cell Biol (1988) 1.03
Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin. Am J Trop Med Hyg (2007) 1.02
Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus. Res Publ Assoc Res Nerv Ment Dis (1978) 1.00
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J Exp Med (1988) 1.00
Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event. Hum Genet (1992) 0.99
Inhibition of DNA binding of purified p55v-myc in vitro by antibodies against bacterially expressed myc protein and a synthetic peptide. EMBO J (1984) 0.98
Splice variants of the human EP3 receptor for prostaglandin E2. Eur J Biochem (1995) 0.98
Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes. J Biol Chem (1999) 0.98
Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents. J Med Chem (1996) 0.97
Transcripts for cysteine-rich secretory protein-1 (CRISP-1; DE/AEG) and the novel related CRISP-3 are expressed under androgen control in the mouse salivary gland. Endocrinology (1993) 0.97
Complex-formation and inhibition of urokinase by blood plasma proteins. Biochem J (1983) 0.95
CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol Cell Biol (1996) 0.93
Biochemical characterization of pp60src-associated protein kinase from avian sarcoma virus Schmidt-Ruppin strain. J Biol Chem (1981) 0.93
Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3eta. Mol Cell Endocrinol (2001) 0.91
Mouse androgen-dependent epididymal glycoprotein CRISP-1 (DE/AEG): isolation, biochemical characterization, and expression in recombinant form. Mol Reprod Dev (1995) 0.91
A family of small nucleoplasmic RNAs with common structural features. Biol Cell (1984) 0.90
A general route to fingerprint analyses of peptide-antibody interactions using a clustered amino acid peptide library: comparison with a phage display library. Mol Immunol (1995) 0.90
Characterization of human zona pellucida glycoproteins. Mol Hum Reprod (1999) 0.90
Involvement of the N-terminal part of cyclophilin B in the interaction with specific Jurkat T-cell binding sites. Biochem J (1996) 0.90
Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4). J Biol Chem (1999) 0.89
Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells. Int J Cancer (1984) 0.89
Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis. Blood (1989) 0.88
Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene (1993) 0.88
Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int (1989) 0.88
Biochemical characterization of transformation-specific proteins of acute avian leukemia and sarcoma viruses. J Cell Biochem (1982) 0.86
Expression of high levels of human tissue plasminogen activator in yeast under the control of an inducible GAL promoter. Appl Microbiol Biotechnol (1992) 0.85
The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene (1991) 0.85
Control elements between -9.5 and -3.0 kb in the human tissue-type plasminogen activator gene promoter direct spatial and inducible expression to the murine brain. Eur J Neurosci (2001) 0.85
Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am J Physiol (1994) 0.84
Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein. J Biol Chem (1986) 0.84
Some characteristics of highly purified boar sperm acrosin. Hoppe Seylers Z Physiol Chem (1974) 0.84
A proenzyme from chicken plasma similar to human plasma prekallikrein. J Biol Chem (1983) 0.84
Comparison of protein kinase activities in normal cells and cells transformed by a temperature-sensitive mutant of avian sarcoma virus to those of cell-free viral translational products. Cold Spring Harb Symp Quant Biol (1980) 0.83
Pantropic retroviral vectors mediate gene transfer and expression in Entamoeba histolytica. Mol Biochem Parasitol (1999) 0.83
Identification of the autoantigen of celiac disease. Ann N Y Acad Sci (1998) 0.82
Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol (1991) 0.82
Differential androgen regulation of the murine genes for cysteine-rich secretory proteins (CRISP). Eur J Biochem (1997) 0.82
Expression of transcripts for cysteine-rich secretory proteins (CRISPs) in the murine lacrimal gland. J Cell Physiol (1999) 0.82
Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells. FEBS Lett (1994) 0.82
cDNA cloning of two closely related forms of human germ cell nuclear factor (GCNF). Biochim Biophys Acta (1997) 0.81
Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-1 (CRISP-1) gene. Biochem J (1997) 0.81
Structural features mediating fibrin selectivity of vampire bat plasminogen activators. J Biol Chem (1995) 0.81
Two 5S genes are expressed in chicken somatic cells. Nucleic Acids Res (1983) 0.81
O-linked L-fucose is present in Desmodus rotundus salivary plasminogen activator. J Biol Chem (1996) 0.81
Conclusions about aminopeptidase in tissue sections from studies of amino acid naphthylamide hydrolysis. Histochemistry (1976) 0.81
Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification. Biochem J (1985) 0.81
Molecular cloning of human endothelin (ET) receptors ETA and ETB. J Cardiovasc Pharmacol (1992) 0.80
Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-3 (CRISP-3) gene. Biochem J (1995) 0.80